摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-环己基-2-苯基-1-乙酮 | 61259-29-8

中文名称
1-环己基-2-苯基-1-乙酮
中文别名
——
英文名称
1-cyclohexyl-2-phenylethanone
英文别名
1-cyclohexyl-2-phenylethan-1-one;Benzylcyclohexylketon;benzyl cyclohexyl ketone
1-环己基-2-苯基-1-乙酮化学式
CAS
61259-29-8
化学式
C14H18O
mdl
——
分子量
202.296
InChiKey
NHBBLULITNXPDY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    79-80 °C
  • 沸点:
    166-167 °C
  • 密度:
    1.0263 g/cm3(Temp: 0 °C)

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 安全说明:
    S24/25
  • 海关编码:
    2914399090

SDS

SDS:8062b38b6f753fbb5e7b15880e24a36b
查看
Name: 1-Cyclohexyl-2-phenyl-1-ethanone 95+% Material Safety Data Sheet
Synonym:
CAS: 61259-29-8
Section 1 - Chemical Product MSDS Name:1-Cyclohexyl-2-phenyl-1-ethanone 95+% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
61259-29-8 1-Cyclohexyl-2-phenyl-1-ethanone 95%+ unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 61259-29-8: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Oil
Color: yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 86 deg C @0.1mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C14H18O
Molecular Weight: 202.3

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 61259-29-8 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-Cyclohexyl-2-phenyl-1-ethanone - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 61259-29-8: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 61259-29-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 61259-29-8 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-环己基-2-苯基-1-乙酮 在 chiral organoaluminum Lewis acid catalyst 二异丁基氢化铝 作用下, 以 二氯甲烷甲苯 为溶剂, 反应 0.5h, 生成 2-cyclohexyl-3-phenyl-2-triethylsiloxypropanal
    参考文献:
    名称:
    使用轴向手性有机铝路易斯酸催化不对称重排 α,α-二取代 α-甲硅烷氧基醛为旋光丙烯醛
    摘要:
    基于立体化学定义的轴向手性有机铝路易斯酸 3 的设计,开发了 α,α-二烷基-α-甲硅烷氧基醛的催化不对称重排。例如,处理 (S,S)-4 (1.1 equiv)在室温下与甲苯中的 Me3Al 反应 30 分钟生成 (S,S)-3 (5 mol %),随后与 α-甲硅烷氧基醛 1a (R = CH2Ph) 在 -20 °C 反应 12 小时,得到平滑的重排得到相应的 α-甲硅烷氧基酮 2a (R = CH2Ph),分离产率为 96%,ee (S) 为 87%。这种前所未有的立体选择性重排的范围已经用代表性底物进行了研究,其中外消旋的 α,α-二取代 α-甲硅烷氧基醛的动力学分辨率也令人印象深刻。
    DOI:
    10.1021/ja063051q
  • 作为产物:
    描述:
    环己甲酸草酰氯 、 (2,2'-bipyridine)nickel(II) dibromide 、 N,N-二甲基甲酰胺 作用下, 以 二氯甲烷N,N-二甲基乙酰胺乙腈 为溶剂, 反应 8.0h, 生成 1-环己基-2-苯基-1-乙酮
    参考文献:
    名称:
    通过CN键裂解,镍催化烷基羧酸衍生物与吡啶鎓盐的交叉偶联。
    摘要:
    羧酸衍生物和烷基吡啶鎓盐通过C–N键断裂的亲电-亲电交叉偶联得到了发展。该方法以其简单性而著称,可指导我们选择各种功能化的酮,产率高至优异。除酰氯外,羧酸还用作酰化剂,这使我们能够结合酸敏感性官能团,例如MOM,BOC和乙缩醛。使用TEMPO进行的对照实验揭示了一个基本途径。
    DOI:
    10.1021/acs.orglett.0c00554
点击查看最新优质反应信息

文献信息

  • Nickel‐Mediated Photoreductive Cross Coupling of Carboxylic Acid Derivatives for Ketone Synthesis**
    作者:Jan Brauer、Elisabeth Quraishi、Lisa Marie Kammer、Till Opatz
    DOI:10.1002/chem.202103486
    日期:2021.12.23
    Mediated synthesis: A strategy for the nickel-catalyzed synthesis of ketones using visible light and two carboxylic acid-derived substrates is presented. No expensive iridium catalysts are required, with eco-friendly Hantzsch ester acting as both the photosensitizer and photoreductant. A broad scope of synthesized ketones is presented along with spectroscopical and computational studies of the role
    介导合成:提出了一种使用可见光和两种羧酸衍生底物镍催化合成酮的策略。不需要昂贵的铱催化剂,环保的 Hantzsch 酯既充当光敏剂又充当光还原剂。介绍了广泛的合成酮以及不同反应物作用的光谱和计算研究。
  • NOVEL AMINO- AND IMINO-ALKYLPIPERAZINES
    申请人:Leonardi Amedeo
    公开号:US20070270436A1
    公开(公告)日:2007-11-22
    Described are novel amino- and iminoalkyl piperazines having affinity for serotonergic receptors and pharmacological compositions thereof. These compounds and their isomers, including optical isomers, enantiomers, diastereomers, N-oxides, polymorphs, hydrates, solvates and pharmaceutically acceptable salts are useful in the treatment of patients with neuromuscular dysfunction of the lower urinary tract and CNS diseases and/or disorders associated with 5-HT 1A receptor dysfunction.
    描述了具有对5-HT1A受体亲和力的新型氨基和亚氨基哌嗪及其药物组合物。这些化合物及其异构体,包括光学异构体、对映异构体、二对映异构体、N-氧化物、多晶形、水合物、溶剂合物和药用可接受盐在治疗患有下尿路神经肌肉功能障碍和与5-HT1A受体功能障碍相关的中枢神经系统疾病和/或紊乱的患者中是有用的。
  • α,β-Epoxy Sulfoxides as Useful Intermediates in Organic Synthesis. I. A Novel Synthesis of Dialkyl Ketones and a Synthesis of Aldehydes from Ketones by One Carbon Elongation
    作者:Tsuyoshi Satoh、Youhei Kaneko、Takao Izawa、Kiichi Sakata、Koji Yamakawa
    DOI:10.1246/bcsj.58.1983
    日期:1985.7
    Treatment of α,β-epoxy sulfoxides, prepared from 1-chloroalkyl phenyl sulfoxides with ketones or aldehydes, with sodium benzeneselenolate gives dialkyl ketones or aldehydes in good yields under mild conditions. The mechanism of this reaction and an application of this process to a formal total synthesis of dihydrojasmone are described.
    用苯硒酸钠处理由 1-氯烷基苯基亚砜与酮或醛制备的 α,β-环氧亚砜,在温和条件下以良好的收率得到二烷基酮或醛。描述了该反应的机理和该过程在二氢茉莉酮的正式全合成中的应用。
  • Asymmetric Catalytic Epoxidation of Terminal Enones for the Synthesis of Triazole Antifungal Agents
    作者:Qianwen He、Dong Zhang、Fengcai Zhang、Xiaohua Liu、Xiaoming Feng
    DOI:10.1021/acs.orglett.1c02588
    日期:2021.9.3
    An enantioselective epoxidation of α-substituted vinyl ketones was realized to construct the key epoxide intermediates for the synthesis of various triazole antifungal agents. The reaction proceeded efficiently in high yields with good enantioselectivities by employing a chiral N,N′-dioxide/ScIII complex as the chiral catalyst and 35% aq. H2O2 as the oxidant. It enabled the facile transformation for
    实现了α-取代乙烯基酮的对映选择性环氧化,构建了合成各种三唑类抗真菌剂的关键环氧化物中间体。通过使用手性N,N'-二氧化物/Sc III配合物作为手性催化剂和 35% 的水溶液,该反应以高产率和良好的对映选择性有效进行。H 2 O 2作为氧化剂。它使光学活性艾沙康唑、依氟康唑和其他潜在的抗真菌剂的转化成为可能。
  • Combined Theoretical and Experimental Studies Unravel Multiple Pathways to Convergent Asymmetric Hydrogenation of Enamides
    作者:Jianping Yang、Luca Massaro、Suppachai Krajangsri、Thishana Singh、Hao Su、Emanuele Silvi、Sudipta Ponra、Lars Eriksson、Mårten S. G. Ahlquist、Pher G. Andersson
    DOI:10.1021/jacs.1c09573
    日期:2021.12.29
    We present a highly efficient convergent asymmetric hydrogenation of E/Z mixtures of enamides catalyzed by N,P–iridium complexes supported by mechanistic studies. It was found that reduction of the olefinic isomers (E and Z geometries) produces chiral amides with the same absolute configuration (enantioconvergent hydrogenation). This allowed the hydrogenation of a wide range of E/Z mixtures of trisubstituted
    我们提出了一种由 N,P-铱配合物催化的E / Z烯酰胺混合物的高效收敛不对称氢化,并得到机理研究的支持。发现烯烃异构体(E和Z几何形状)的还原产生具有相同绝对构型的手性酰胺(对映收敛氢化)。这允许以优异的对映选择性(高达 99% ee)。使用氘标记和动力学实验的详细机理研究揭示了观察到的对映收敛的两种不同途径。对于 α-芳基烯酰胺,双键发生快速异构化,整个过程导致两种异构体的动力学拆分。对于 α-烷基烯酰胺,没有检测到双键异构化,竞争实验表明底物螯合是对映收敛立体化学结果的原因。进行 DFT 计算以预测产物的正确绝对构型并加强提出的铱催化异构化途径的机制。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐